Skip to Navigation
Social Contribution
Ethics & Compliance
C&C News
Recruitment
Sitemap
Korean
Message from CEO
Background
Mission & Vision
JW WAY
History
Research Activity
R&D Research Strategy
R&D Pipeline
Core Technology
Strength of C&C
Contact us
Q&A
Map
Research Activities
and Results
R&D Research Strategy
R&D Pipeline
Core Technology
Strength of C&C
>
Discovery Research
>
Strength of C&C
Excellent research competence focused on discovery research
Development of first-in-class drugs in the field of cancer and immune disease
New target discovery and drug mechanism research utilizing genomic information
Drug discovery platform with small molecules
Successful research experiences in various disease area
Operation of intra-functional matrix cooperation system to enhance research efficiency
Various animal models to evaluate cancer and immune diseases
Genomic DB for a variety of cancer cell lines derived from Korean cancer patients
High-throughput screening system (Cell biology)
Cell / tissue bank and chemical library
High-end equipment, facility and IT infrastructure
Discovery of new target through the collaboration with domestic and foreign frontier
groups in the field of cancer and immune disease.
JW Pharmaceutical
- Research collaboration (Sharing research information/technology/infrastructure)
- Regular consulting from mother companies on discovery research
Research collaboration , education of researchers, use of facilities with university